Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other ITP symptoms ITP is a rare disease of complex immune dysregulation leading to ...
Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...
Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...
Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...
The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...
Sanofi (SNYNF) announced an update on their ongoing clinical study.
Zacks Investment Research on MSN
FDA issues CRL to SNY's regulatory filing for multiple sclerosis drug
Sanofi SNY announced that the FDA has issued a complete response letter (CRL) to its new drug application (NDA), seeking ...
Johnson & Johnson today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a Phase 3 ...
WE’VE all been there… an explained deep purple mark appearing out of seemingly nowhere, on your arm the morning after the ...
TipRanks on MSN
Sanofi announces European Commission approval of Wayrilz
The European Commission has approved Wayrilz, a novel, oral, reversible, Bruton’s tyrosine kinase inhibitor, as a new treatment for immune ...
Tatiana Schlossberg, a journalist and granddaughter of President John F. Kennedy, has died at 35 after a battle with cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback